Discover how to get the most out of your patient engagement programs while protecting your brand from regulatory non-compliance at a new Manatt webinar.

Life sciences companies are increasingly providing treatment-related items and services to support patients, such as nebulizers, utilization tracking tools and home health visits. Proactive engagement strategies can achieve a host of critical objectives—from increasing medication adherence to informing clinical studies to shedding new light on the patient journey. They also, however, can present potential regulatory pitfalls.

How can you engage patients effectively while protecting your company from regulatory risks? How can you provide benefits to patients while keeping your brand safe? What are the challenges to patient engagement—and how can you overcome them? Manatt Health provides the answers in a new CLE-eligible webinar. Key topics include:

• A look at real-world patient engagement and benefit programs through the regulatory lens of the Beneficiary Inducement Statute and the Anti-Kickback Statute
• An analysis of services, products and information provided in patient programs—and whether they qualify for safe harbor protections, such as access to care and nominal value exceptions
• A review of real-world case studies demonstrating whether it is acceptable to tie certain benefits to particular brands
• A guide to best practices that optimize program effectiveness while ensuring regulatory compliance

Date and Time

Thursday, May 7, 2020

If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at webinars@manatt.com.

This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.